Association of white blood cell subfraction concentration with fitness and fatness

British Journal of Sports Medicine

Volumn 44, Issue 8, 2010, Pages 588-593

  Johannsen, N M ^a   Priest, E L ^b   Dixit, V D ^a   Earnest, C P ^a   Blair, S N ^c   Church, T S ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b BAYLOR HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; EXERCISE; FITNESS; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; OBESITY; OXYGEN CONSUMPTION; PATHOLOGY; PHYSIOLOGY;

BODY MASS INDEX; CROSS-SECTIONAL STUDIES; EXERCISE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MIDDLE AGED; OBESITY; OXYGEN CONSUMPTION; PHYSICAL FITNESS;

EID: 77953818593     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsm.2008.050682     Document Type: Article

References (48)

1. Gillum RF, Mussolino ME, Madans JH. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 2005;15:266-71.
2. Gillum RF, Ingram DD, Makuc DM. White blood cell count, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 1993;125:855-63.
3. Weijenberg MP, Feskens EJ, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 1996;16:499-503.
4. Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001;54:316-22.
5. de Labry LO, Campion EW, Glynn RJ, et al. White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. J Clin Epidemiol 1990;43:153-7.
6. Grimm RH Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 1985;254:1932-7.
7. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992;267:1253-6.
8. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477-82.
9. Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638-43.
10. Rana JS, Boekholdt SM, Ridker PM, et al. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study. J Intern Med 2007;262:678-89.
11. Hoffmeister A, Rothenbacher D, Bazner U, et al. Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol 2001;87:262-6.
12. Huang ZS, Jeng JS, Wang CH, et al. Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. Atherosclerosis 2001;158:431-6.
13. Church TS, Finley CE, Earnest CP, et al. Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. Int J Obes Relat Metab Disord 2002;26:805-13.
14. Nieman DC, Henson DA, Gusewitch G, et al. Physical activity and immune function in elderly women. Med Sci Sports Exerc 1993;25:823-31.
15. Nieman DC, Nehlsen-Cannarella SL, Fagoaga OR, et al. Immune function in female elite rowers and non-athletes. Br J Sports Med 2000;34:181-7.
16. Nieman DC, Buckley KS, Henson DA, et al. Immune function in marathon runners versus sedentary controls. Med Sci Sports Exerc 1995;27:986-92.
17. Nieman DC, Brendle D, Henson DA, et al. Immune function in athletes versus nonathletes. Int J Sports Med 1995;16:329-33.
18. Nieman DC, Henson DA, Nehlsen-Cannarella SL, et al. Influence of obesity on immune function. J Am Diet Assoc 1999;99:294-9.
19. Dixon JB, O'Brien PE. Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg 2006;16:251-7.
20. Herishanu Y, Rogowski O, Polliack A, et al. Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol 2006;76:516-20.
21. Marlatt GA, Gordon JR, Davidson PO. Determinants of relapse: Implications for the maintenance of behavior change. In: Davidson PO, ed. Behavioral medicine: Changing health lifestyles. Elmsford, NY: Pergamon, 1980:410-52.
22. Balke B, Ware RW. An experimental study of physical fitness in Air Force personnel. U S Armed Forces Med J 1959;10:675-88.
23. Pollock ML, Bohannon RL, Cooper KH, et al. A comparative analysis of four protocols for maximal treadmill stress testing. Am Heart J 1976;92:39-46.
24. Blair SN, Wei M, Lee CD. Cardiorespiratory fitness determined by exercise heart rate as a predictor of mortality in the Aerobics Center Longitudinal Study. J Sports Sci 1998;16: S47-S55.
25. Bouchard C, Pérusse L, Bouchard C, et al. Heredity, activity level, fitness, and health. In: Bouchard C, Shephard RJ, Stephens T, eds. Physical activity, fitness, and health: International proceedings and consensus statement. Champaign, Illinois: Human Kinetics Publishers, 1994:106-18.
26. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
27. Chakraborti T, Mandal A, Mandal M, et al. Complement activation in heart diseases. Role of oxidants. Cell Signal 2000;12:607-17.
28. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872-85.
29. Zarbock A, Ley K. Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol 2008;172:1-7.
30. Blair SN, Kohl HW III, Paffenbarger RS Jr, et al. Physical fitness and all-cause mortality: a prospective study of healthy men and women. JAMA 1989;262:2395-401.
31. Ekelund LG, Haskell WL, Johnson JL, et al. Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men: The Lipid Research Clinic's mortality follow-up study. N Engl J Med 1988;319:1379-84.
32. Proceedings of conference on nutrition and physical activity to optimize performance and well-being. Atlanta, Georgia; 5-7 April 1995. Nutrition Reviews 1996;54: S1-183.
33. Cottam DR, Schaefer PA, Shaftan GW, et al. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes Surg 2002;12:335-42.
34. Dixon JB, Anderson M, Cameron-Smith D, et al. Sustained weight loss in obese subjects has benefits that are independent of attained weight. Obes Res 2004;12:1895-902.
35. Hanusch-Enserer U, Cauza E, Spak M, et al. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord 2003;27:355-61.
36. McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: Down-regulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses 1999;52:465-77.
37. Suzuki K, Yamada M, Kurakake S, et al. Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans. Eur J Appl Physiol 2000;81:281-7.
38. Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409-15.
39. Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995;95:2111-19.
40. Zarkesh-Esfahani H, Pockley AG, Wu Z, et al. Leptin indirectly activates human neutrophils via induction of TNF-alpha. J Immunol 2004;172:1809-14.
41. Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004;114:57-66.
42. Tsukui S, Kanda T, Nara M, et al. Moderate-intensity regular exercise decreases serum tumor necrosis factor-alpha and HbA1c levels in healthy women. Int J Obes Relat Metab Disord 2000;24:1207-11.
43. Smith JK, Dykes R, Douglas JE, et al. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 1999;281:1722-7.
44. Volpato S, Guralnik JM, Ferrucci L, et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 2001;103:947-53.
45. Taaffe DR, Harris TB, Ferrucci L, et al. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 2000;55: M709-M715.
46. Ghanim H, Aljada A, Hofmeyer D, et al. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004;110:1564-71.
47. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-7.
48. Brodney S, McPherson RS, Carpenter RA, et al. Nutrient intake of physically fit and unfit men and women. Med Sci Sports Exerc 2001;33:459-67.